Abiopharma

🔍 CIULLA JOHN R (Director)

Company: WEBSTER FINANCIAL CORP (WBS)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Acquired 105,830 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 395,668.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 28,537 shares of Common Stock at $79.07 per share (Direct)
  Date: 2026-08-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 367,131.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 7,048 shares of Common Stock at $79.07 per share (Direct)
  Date: 2026-08-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 360,083.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: H | nature_of_ownership: 401(k)Plan | shares_owned_after: 17,187.16

Footnotes:

• F1: Represents the vesting of certain performance shares that were accelerated pursuant to the Transaction Agreement, dated as of February 3, 2026, by and among Webster Financial Corporation, Banco Santander, S.A. and Webster Virginia Corporation.
• F2: Represents the tax withholding upon the vesting of certain performance shares that were accelerated pursuant to the Transaction Agreement, dated as of February 3, 2026, by and among Webster Financial Corporation, Banco Santander, S.A. and Webster Virginia Corporation.
• F3: Represents the tax withholding upon the vesting of certain time-based restricted shares that were accelerated pursuant to the Transaction Agreement, dated as of February 3, 2026, by and among Webster Financial Corporation, Banco Santander, S.A. and Webster Virginia Corporation.